Atlas Trials

A Positron Emission Tomography (PET) Study to Evaluate Dopamine D2 and D3 Receptor Occupancy by SIPI6398

Clinical trial NCT07626034 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07626034
Sponsor
Shanghai Zhongze Therapeutics Co., Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Schizophrenia Disorder
Start date
2026-08-01
Primary completion
2027-10-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.